NEO: Quick note
NEO reported Q4 numbers last week, mostly in line and with continued positive numbers on test volume growth and margin increases. They reported that most of the TC grandfather sunset is now behind them, they have added 4 new sales reps and continue to guide up. Share price has responded positively and today is trading at an all-time high (currently $3.38/share).
For those watching, we continue to be on track with long-term growth and establishment as a legitimate stock, now fully listed. If the share value can reach and sustain $4/share, the co. will be available for more institutional investment and will likely shoot past the $4 threshold, given the reasonable no. of outstanding shares (45 million) and float (16.5 million).
The only drawback I see in the short-term would be the sequester, which would cut medicare reimbursement 2% across the board.
